Target Brands, Inc.

Mindray Ds Usa, Inc.

Helen of Troy Limited

Haemonetics Corporation

Cequr Sa

Abbott Laboratories Corporation

Amgen Inc.

Cooper Technologies Company

Abbott Medical Optics Inc.

Ric Investments, Inc.

Johnson & Johnson Surgical Vision, Inc.

Heartware, Inc.

Neuronetics, Inc.

Allan Lee Cameron

Robert D Peota

Alexandre Hennen

William D Splain

Mark T Ryan

David L Pruitt, Jr

Nicholas Evan Barker

James D Wilson

David M Chastain

Peter B Schon

Geoffrey C Jawidzik

James Patrick Thrower

Brian Stonecipher

James Fidacaro

Philip Charles Walker

Gregg Allen Flender

Fred C Lee

Damien Vizcarra

Roy Alden Thompson

Ann Marie Sullivan

Kyle E Lynn

David W Laituri

Christopher James Page

Kenneth E Kadziauskas

Margaux Frances Boyaval

James P Perry

Mark Edward Riehl

Jim Wilson

John R Bussiere

Andrew J Boyce

Gaurav Rohatgi

Tapan Patel

Kelvin Kao

Tonia Giesecke

Tuan Tom Tran

Jeremy Paul Zietz

Paul C Gregory

Hilary Farnsworth

Regan A Pierce

Teresita Smith

Dean Francis DiPietro

Patrick P McDermott

Steven B Radney

Roy A Thompson

Christopher James McCracken

Mark William Dimatteo

Richard A Seman

Michael Bobeck

Maxwell Franklin Bischoff

William J Palm

James Chan

Michael Eugene Mort

Jeffrey Kepler

John J Kropczynski, Jr

Mark DiMatteo

Avon Kuo

Paul Crosby Gregory

Zach Traina

Thomas Gerard Parent

John A MacNeill

Meghan Walter

John Wadsworth

Hiroshi Kira

Dennis Kopilec

Christine Ciccone

James S Vreeland

Ken Kadziauskas

Christopher J Page

Patrick F McDormott

Guerav Rohatgi

John A Mac Neill

Christopher J Mccracken

David P Chastain

Patrick F Mcdermott

Tuan Tran

Kyle Lynn

John J Kropczynski

A wearable drug delivery device includes an injector having a housing, a reservoir, a needle or cannula, a drive mechanism for urging drug product out of the reservoir, through the needle or cannula, and to a patient, and an activator mechanism disposed on a surface of the housing for activating the drive mechanism. An activation prevention mechanism is coupled to the injector housing and/or activation prevention mechanism to prevent inadvertent actuation of the activator mechanism.

Drug delivery device with activation prevention feature

A phacoemulsification system and method, and a surgical foot pedal device, system and method. The present invention may include a console comprising a plurality of modes for at least one physically associated surgical instrument, and a foot pedal communicatively associated with said console and suitable for varying ones of the plurality of modes. The foot pedal may include a housing comprising the communicative association, and comprising at least one potentiometer and at least two top switches for the varying of the ones of the plurality of modes, a treadle rotatably mounted within the housing and suitable for depressing the at least one potentiometer, and at least two side switches movably associated with the treadle for the varying of the ones of the plurality of modes.

Foot pedal system and apparatus

An alignment device for an external coil in a transcutaneous energy transfer (TET) system. The device may be adhered to the skin or clothing of a patient and may ensure alignment between an external coil and an internal coil to provide optimal energy transfer in a TET system.

Self-adhesive TET coil holder with alignment feature

Foot pedal

Patient monitoring systems can include a display unit and a patient parameter module. The patient parameter module can be connected to a docking region so as to communicate with the display unit in two or more orientations.

Modules for monitoring patients and related systems and methods

An enteral connector assembly and system () communicates fluid between a bag B' or a bottle B&#x2033; and an enteral feeding set. The system () includes an end cap () that communicates enteral fluid across a barrier () having a specially configured barrier keyway () formed with a barrier port (). The barrier () establishes an interstice () that when combined with the spike barrier () prevents introduction of and fluid communication with legal intravenous spikes (LS) and other incompatible connectors, while enabling connection to and fluid communication with compatible components such as an interconnect () having multiple tines () that include specially shaped tips () that extend across the interstice () to pierce a seal, septum, and/or sealing membrane and form a fluid pathway.

Enteral connectors and systems

Patient monitoring systems can include a docking station and a display unit. The display unit can be coupled with the docking station or decoupled from the docking station. Some display units can include one or more actuators that aid in decoupling the display unit from the docking station that can be actuated while the display unit is being gripped.

Growing community of inventors

Natick, MA, United States of America

Allan Lee Cameron